Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition

Christopher Szeto, Joseph Bloom, Hannah Sloane, Christian A. Lobos, James Fodor, Dhilshan Jayasinghe, Demetra S.m. Chatzileontiadou, Emma J. Grant, Ashley M. Buckle, Stéphanie GrasInternational Journal of Molecular Sciences 2020 · DOI

TL;DR

This study reveals that Human Leukocyte Antigen (HLA) class II molecules, specifically HLA-DR, exhibit a surprisingly rigid antigen-binding cleft, contrary to expectations for dynamic interactions. This rigidity, driven by polymorphic residues, dictates how T cell receptors (TCRs) recognize and bind to these complexes, influencing the strength and outcome of T cell responses.

What Problem Does This Paper Address?

The immune system relies on T cells recognizing foreign peptides presented by Major Histocompatibility Complex (MHC) molecules, like HLA, on cell surfaces. This recognition is mediated by the T cell receptor (TCR) binding to the peptide-HLA (pHLA) complex. While crystal structures offer static snapshots of these interactions, the dynamic nature of pHLA molecules and their TCR interactions is crucial for understanding T cell activation. Previous studies on HLA class I suggested significant flexibility. However, the dynamics of HLA class II, particularly HLA-DR, and how their inherent structural variations (polymorphisms) influence TCR binding and subsequent immune responses, remained less clear. This paper aims to elucidate the structural basis for differential TCR binding affinities to various HLA-DR allomorphs presenting the same peptide.

Methods

The researchers employed a multi-pronged approach combining computational and experimental techniques:

  • Molecular Dynamics (MD) Simulations: Used to simulate the movement of atoms and molecules over time, providing insights into the dynamic behavior of HLA-DR molecules in both free and TCR-bound states. This allowed for the assessment of flexibility and conformational changes.
  • Crystallographic Ensemble Refinement: This advanced technique extends traditional X-ray crystallography by refining against multiple experimental reflections to generate an ensemble of structurally distinct models. This ensemble captures the conformational landscape consistent with the experimental data, offering a more dynamic view than a single static structure.
  • Thermal Shift Assays: Used to measure the thermal stability of pHLA-DR complexes. This involves monitoring the unfolding of proteins as they are heated, with the melting temperature (Tm) indicating stability.
  • Fluorescence Polarization Assays: Employed to determine peptide binding affinities and assess the influence of HLA-DM on peptide exchange. This method measures changes in fluorescence polarization to quantify binding interactions.

Datasets

The study utilized existing crystal structures of pHLA-DR complexes from the Protein Data Bank (PDB). Specifically, they analyzed 43 pHLA-DR structures that met their criteria, including structures of HLA-DR1, HLA-DR11, and HLA-DR15 complexed with the RQ13 peptide, as well as other pHLA-DR structures with various peptides.

Key Insights and Ideas

  • Unexpected Rigidity of HLA-DR Cleft: Contrary to expectations for dynamic interactions, the study found that the antigen-binding cleft of HLA-DR molecules is remarkably rigid. This suggests that conformational selection, rather than induced fit, might be a primary mechanism for TCR recognition.
  • Polymorphic Residues as Sculptors: While the overall cleft is rigid, polymorphic residues within HLA-DR play a critical role in shaping the cleft's dimensions and influencing interactions. These variations, rather than flexibility, are key to differential TCR binding.
  • HLA-DR1's Robustness: HLA-DR1 exhibits significantly higher protein stability and lower susceptibility to HLA-DM-mediated peptide exchange compared to other HLA-DR allomorphs. This suggests HLA-DR1 is a more stable and potentially more versatile peptide presenter.
  • Peg-Notch Interaction Dynamics: The study detailed a specific "peg-notch" interaction between the TCR and the pHLA complex, highlighting how polymorphic residues in HLA-DR can disrupt this interaction, leading to varied TCR binding affinities.

Key Results

  • Rigid Cleft Confirmed: MD simulations and ensemble refinement consistently showed a rigid antigen-binding cleft across all investigated HLA-DR allomorphs, regardless of peptide or TCR binding.
  • Differential TCR Affinity Explained: Polymorphisms in HLA-DR, particularly at positions like HLA-DRβ67, were shown to influence the opening/closing of the cleft and the stability of key interactions (e.g., the peg-notch interaction), directly correlating with the observed hierarchy of F24 TCR binding affinities.
  • HLA-DR1 Stability: Thermal shift assays revealed that HLA-DR1 is significantly more stable than HLA-DR11, even when presenting the same peptides, including the CLIP peptide.
  • HLA-DM Susceptibility: Fluorescence polarization assays demonstrated that HLA-DR1 is less susceptible to HLA-DM-mediated peptide exchange compared to HLA-DR11, suggesting a more stable interaction with its presented peptide.

Limitations and Future Work

  • Snapshot of Rigidity: While ensemble refinement provides a dynamic view, it is still based on crystallographic data. The study acknowledges that this might not capture all possible large-scale dynamic motions.
  • RQ13 Peptide Specificity: The initial focus was on the RQ13 peptide. While the study expanded to other pHLA-DR structures, further investigation into the impact of different peptides on HLA-DR dynamics and rigidity would be beneficial.
  • Implications for Autoimmunity: The authors suggest that the stability and peptide repertoire of HLA-DR1 might influence its role in immune responses, hinting at potential implications for autoimmune diseases, which warrants further exploration.
  • Broader HLA-II Dynamics: The study focused on HLA-DR. Extending these dynamic analyses to other HLA class II molecules (DQ, DP) could provide a more comprehensive understanding of MHC class II behavior.

Summary updated

Abstract

The interaction between T cell receptor (TCR) and peptide (p)-Human Leukocyte Antigen (HLA) complexes is the critical first step in determining T cell responses. X-ray crystallographic studies of pHLA in TCR-bound and free states provide a structural perspective that can help understand T cell activation. These structures represent a static "snapshot", yet the nature of pHLAs and their interactions with TCRs are highly dynamic. This has been demonstrated for HLA class I molecules with in silico techniques showing that some interactions, thought to stabilise pHLA-I, are only transient and prone to high flexibility. Here, we investigated the dynamics of HLA class II molecules by focusing on three allomorphs (HLA-DR1, -DR11 and -DR15) that are able to present the same epitope and activate CD4+ T cells. A single TCR (F24) has been shown to recognise all three HLA-DR molecules, albeit with different affinities. Using molecular dynamics and crystallographic ensemble refinement, we investigate the molecular basis of these different affinities and uncover hidden roles for HLA polymorphic residues. These polymorphisms were responsible for the widening of the antigen binding cleft and disruption of pHLA-TCR interactions, underpinning the hierarchy of F24 TCR binding affinity, and ultimately T cell activation. We expanded this approach to all available pHLA-DR structures and discovered that all HLA-DR molecules were inherently rigid. Together with in vitro protein stability and peptide affinity measurements, our results suggest that HLA-DR1 possesses inherently high protein stability, and low HLA-DM susceptibility.
BibTeX
@article{szeto2020impact,
  author = {Christopher Szeto and Joseph Bloom and Hannah Sloane and Christian A. Lobos and James Fodor and Dhilshan Jayasinghe and Demetra S.M. Chatzileontiadou and Emma J. Grant and Ashley M. Buckle and Stéphanie Gras},
  title = {{Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition}},
  journal = {International Journal of Molecular Sciences},
  year = {2020},
  doi = {10.3390/ijms21197081},
}
Figure